Tag: Mary Lehner
Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
South Korea’s maritime hub status grows with advanced ports, shipbuilding strength, trade volumes and dispute resolution.